Thetford Mines, Quebec – December 10, 2019 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is proud to announce through its subsidiary AlliancePharma, the development of an education program for pharmacists and technicians about cannabis-based medical products.
- kDa Group develops a technological platform for its subsidiary AlliancePharma
- kDa Group develops a cannabis-based medical products eduction program for pharmacists and technicians
- Expansion of the CanNorth Medic plant for cannabis-based medical products
- KDA Group completes debt settlement
- KDA Group announces appointment of new Director, Mr. Stan Bharti